Eric Jia-Sobota, Founder, Max Higgins, Consultant, Author at EverGlade Consulting

Webinar Alert: R&D Funding in Life Sciences: What’s Ahead in Trump 2.0?

Leave a Comment / EverGlade Insights / By Max Higgins, Consultant

What to Expect in the Webinar: Federal Programs at Risk: Explore which key life sciences programs might face funding challenges in a new Trump administration. Emerging Opportunities: Learn about research areas poised to gain new momentum and potential funding in the evolving political landscape. Key Players Shaping Change: Get insights into the policymakers and influencers […]

Webinar Alert: R&D Funding in Life Sciences: What’s Ahead in Trump 2.0? Read More »

Leveraging AI to Enhance Business Intelligence

Leave a Comment / DIU, EverGlade Insights, Time Sensitive / By Max Higgins, Consultant

DOD’s New Initiative_AOI Solicitation Leveraging AI to Enhance Business Intelligence: The DoD’s New Initiative The Department of Defense (DoD) has identified a critical need to modernize business intelligence assessments to keep pace with evolving challenges in due diligence evaluations and industrial foreign influence analyses. To address this, the Defense Innovation Unit (DIU) has released an

Leveraging AI to Enhance Business Intelligence Read More »

ARPA-H_EIH health and biomedical research

Emerging Health Innovators (EHI) Initiative

Leave a Comment / ARPA-H, EverGlade Insights, NIH / By Max Higgins, Consultant

ARPA_H_SOL_25_118_EHI_Solicitation (1) Emerging Health Innovators Solicitation: An Opportunity to Revolutionize Health Innovation The Advanced Research Projects Agency for Health (ARPA-H) has issued the Emerging Health Innovators (EHI) Initiative Solicitation (ARPA-H-SOL-25-118), a groundbreaking funding opportunity aimed at empowering both early-career researchers and community innovators to advance health and biomedical research. Through the EHI Initiative, ARPA-H seeks

Emerging Health Innovators (EHI) Initiative Read More »

MTEC RPP medical techniques, knowledge products, and materials

EverGlade Consulting Funding Alert: MTEC Fiscal Year 2025 Multi-Topic Request for Project Proposals

Leave a Comment / EverGlade Insights, MTEC / By Max Higgins, Consultant

MTEC-25-04-MultiTopic-RPP_Final Overview of the Solicitation The Medical Technology Enterprise Consortium (MTEC) has recently announced its Fiscal Year 2025 Multi-Topic Request for Project Proposals (RPP). This RPP focuses on eleven key Focus Areas to stimulate innovative medical prototype, technological, and knowledge solutions with military relevance. The RPP targets the following focus areas: Focus Area 1 –

EverGlade Consulting Funding Alert: MTEC Fiscal Year 2025 Multi-Topic Request for Project Proposals Read More »

EverGlade Consulting Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID)

Leave a Comment / ARPA-H, EverGlade Insights / By Max Higgins, Consultant

RAPID_Special_Notice ARPA-H’s RAPID Program The Advanced Research Projects Agency for Health (ARPA-H) recently announced the newly approved program for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID). This initiative aims to revolutionize the prolonged diagnostic odyssey faced by millions of rare disease patients worldwide. Utilizing fragmented datasets and state-of-the-art technologies, RAPID aims to democratize access

EverGlade Consulting Funding Alert: Proposer’s Day for Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Read More »

EverGlade Consulting Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR)

Leave a Comment / ARPA-H, EverGlade Insights / By Max Higgins, Consultant

ARPA-H-SOL-25-125_Special_Notice ARPA-H’s PROSPR Program The Advanced Research Projects Agency for Health (ARPA-H) has announced the PROactive Solutions for Prolonging Resilience (PROSPR) initiative, an ambitious program designed to extend the healthspan of Americans by addressing the underlying causes of age-related health loss. By pioneering innovative interventions that target age-induced health deterioration, ARPA-H aims to revolutionize healthcare

EverGlade Consulting Funding Alert: PROactive Solutions for Prolonging Resilience (PROSPR) Read More »

Radiation & Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices

Leave a Comment / EverGlade Insights, NIAID, Time Sensitive / By Max Higgins, Consultant

NIAID_Presolicitation_Notice_Rad_Nuc MCMs Overview of Solicitation The National Institute of Allergy and Infectious Diseases (NIAID), under the National Institutes of Health (NIH), has released a pre-solicitation notice for the development of Radiation/Nuclear Medical Countermeasures (MCMs) and Biodosimetry Devices. This Broad Agency Announcement (BAA 75N93024R00020) is an invitation for innovators in the critical field of radiation emergency

Development of Radiation/Nuclear Medical Countermeasures And Biodosimetry Devices Read More »

Transforming Clinical Trials with the Advancing Clinical Trial Readiness (ACTR) Initiative

Leave a Comment / ARPA-H, EverGlade Insights / By Max Higgins, Consultant

ARPA-H launches groundbreaking funding opportunity The Advancing Clinical Trial Readiness (ACTR) Initiative, spearheaded by ARPA-H’s Resilient Systems Office (RSO), aims to revolutionize clinical trials by developing a decentralized, efficient, and accessible infrastructure. Overview of Solicitation The ACTR Initiative is focused on creating tools, networks, and infrastructure to enable decentralized and on-demand clinical trials. By integrating

Transforming Clinical Trials with the Advancing Clinical Trial Readiness (ACTR) Initiative Read More »

ARPA-H health equity, technology, and biomedical research

Emerging Health Innovators (EHI) Initiative Proposer’s Day

Leave a Comment / ARPA-H, EverGlade Insights / By Max Higgins, Consultant

ARPA-H-SN-25-119 (1) The Advanced Research Projects Agency for Health (ARPA-H) has launched the Emerging Health Innovators (EHI) Initiative, a transformative funding opportunity aimed at empowering early-career researchers and community-based innovators to revolutionize healthcare. To support this initiative, ARPA-H is holding a virtual Proposer’s Day on January 8th, 2025, from 11AM to 4PM EDT. Overview of

Emerging Health Innovators (EHI) Initiative Proposer’s Day Read More »

medical countermeasures for biodefense and infectious diseases

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease

Leave a Comment / EverGlade Insights, NIAID, NIH / By Max Higgins, Consultant

HHS-NIH-NIAID-BAA2025-1 The U.S. Department of Health and Human Services (HHS), through the National Institutes of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID), has released the Broad Agency Announcement (BAA) HHS-NIH-NIAID-BAA2025-1. This announcement presents an exciting opportunity for researchers, organizations, and industry leaders to contribute to critical biomedical and biodefense initiatives.

Omnibus Solicitation Seeks Medical Countermeasures for Biodefense and Emerging Infectious Disease Read More »

the Joint Biological Tactical Detection System

Joint Biological Tactical Detection System Full Rate Production Request for Information

Leave a Comment / EverGlade Insights, JPEO / By Max Higgins, Consultant

JBTDS_FRP_RFI_4_Nov_2024_ The U.S. Army’s Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) recently issued a Request for Information (RFI) regarding Full Rate Production (FRP) of the Joint Biological Tactical Detection System (JBTDS). This RFI aims to collect information on industry capability to produce JBTDS devices which will be used by joint

Joint Biological Tactical Detection System Full Rate Production Request for Information Read More »

Assay Expansion for Chemical Diagnostic System

Leave a Comment / DTRA, EverGlade Insights / By Max Higgins, Consultant

Assay-Expansion-for-Chemical-Diagnostics-System-SOO_Final The Defense Threat Reduction Agency’s Medical Diagnostics Branch (RD-CBMD) is driving innovation with its 2026 solicitation to expand the ChemDx platform. ChemDx is a handheld diagnostic device for rapid detection of chemical threats, such as nerve agents or certain pesticides, in blood from a finger prick. This effort seeks proposals from organizations interested in

Assay Expansion for Chemical Diagnostic System Read More »

Max Higgins, Consultant

EverGlade Consulting

2025 Proposal Package